Learn More
Apexbio Technology LLC AP26113, 5mg. Cas: 1197958-12-5 MFCD: MFCD23704187. Anaplastic lymphoma kinase (ALK) inhibitor

Supplier: Apexbio Technology LLC A13675
AP26113 is a novel, synthetic, orally available small-molecule inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase in the insulin receptor superfamily, with half maximal inhibitory concentration IC50 ranging from 5 nmol/l to 11 nmol/l. Other sizes are available. Please inqury us for quote.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.